Long reads
Gene therapy gathers pace
Sarah Houlton charts the evolution, challenges and opportunities of cell and gene therapy
Understanding Alzheimer’s
After hundreds of failed drug candidates, James Mitchell Crow asks if this is the last roll of the dice for the amyloid theory of Alzheimer’s disease
Big business computing
Chemical and oil firms are using supercomputers to improve every part of their operations. Angeli Mehta reports
Profiles
Rural power champion
Clementine Chambon is the 2018 Chemistry World Entrepreneur of the Year for her work using bioenergy to solve environmental, social and gender challenges in rural India
From chemist to patent attorney
How to make the career switch
The glue entrepreneurs
The business novices who launched global sticky success Sugru
Amplifying intelligent drug design
This year’s Chemistry World Entrepreneur of the year is Andrew Hopkins of start-up Exscientia and the University of Dundee, UK
Opinion
Finding the missing mass
When the numbers don’t add up, chemists must restore the balance
For the sake of argument
It’s important to recognise which disputes can actually be resolved by science
Something to declare on Brexit
As it stands, there is no credible model of a Brexit agreement which does not weaken the competitiveness of the UK chemical industry
Beyond buckets and batches
Embracing flow chemistry means leaving behind some faithful friends
More Business News
$10bn cracker for China
Project would be BASF’s largest ever investment
J&J hit with bill for $4.7 billion in damages over talcum powder cancer link
Pharmaceutical and consumer goods giant loses another talc court case to 22 ovarian cancer patients
J&J and the question of shadow research
Former academic researcher who found that talc is not carcinogenic admits that J&J funded his work, but says that fact is immaterial
Ube’s management pays for lax quality checks
Japanese chemical maker announces that ‘quality-related improprieties’ were detected in 24 of its products, including low-density polyethylene
Bayer–Monsanto merger momentum
US antitrust regulators approve Bayer’s $66bn takeover of Monsanto, conditional on the company offloading $9bn in assets
US chemical safety agency wants Arkema disaster to spark real change
Industry guidance is needed to help hazardous chemical facilities better prepare for extreme weather events like flooding, the CSB warns
Deal protects world’s biggest selling drug from biosimilar erosion
AbbVie and Samsung Bioepis resolve patent litigation over arthritis drug Humira
India creates national drugs database to address supply and quality issues
Novartis’ $8.7bn AveXis deal shows gene therapy appeal
AkzoNobel sells off specialty chemicals arm in €10bn deal
US steel and aluminium tariffs threaten chemical and plastics sectors
Outline for Europe’s first waste to methanol plant
Indian court seizes former Ranbaxy owners’ assets
DowDupont names its three new separate businesses
Takata settles with US states over faulty airbag inflators
Chemist caught stealing and dumping cyanide
BMS stimulates cancer drug hopes with giant collaboration
